A lawyer who says she gave a drug company the idea to use thalidomide as a cancer treatment has won the right to pursue a claim that the company reneged on the promise of a reward and owes her $300 million. A New Jersey federal judge ruled last week that Beth Jacobson, who allegedly gave Celgene Corp. the thalidomide idea in 1997, can engage in discovery to defeat its motion for dismissal of the suit as time-barred. The judge also denied Celgene's motion for dismissal for failure to state a claim.
April 19, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A lawyer who says she gave a drug company the idea to use thalidomide as a cancer treatment has won the right to pursue a claim that the company reneged on the promise of a reward and owes her $300 million.
U.S. District Judge Faith Hochberg in Newark, N.J., ruled on Wednesday that Beth Jacobson, who allegedly gave Celgene Corp. the thalidomide idea in 1997, can engage in discovery to defeat its motion for dismissal of the suit as time-barred.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
